Medical Science Research Bulletin

Introduction: Scleromyositis (SM) represents an overlap syndrome between scleroderma and inflammatory myopathy. It is the most common of the overlapping syndromes.

Observation: The authors report a case of scleromyositis in a 26-year-old woman. The diagnosis was facilitated by the presence of myalgia in the anterior aspect of the left leg, as detected by magnetic resonance imaging (MRI) of the left thigh, which revealed edema involving the intermedial vastus and the medium gluteal muscles. Muscle enzymes were normal, but electroneuromyogram revealed a neuropathic pattern. Furthermore, antinuclear antibodies (ANA) were found to be positive using indirect immunofluorescence on Hep 10-20 slides, with a titer of 1/160, a speckled appearance and anti-polymyositis/scleroderma antibodies were identified. The patient was treated with corticosteroids and then immunosuppressants, with a favorable clinical response.

Conclusion: Muscle MRI can facilitate the diagnosis of scleromyositis in countries where access to muscle biopsy is challenging.

scleromyositis, inflammatory myopathy, Togo.

1. Iaccarino L, Gatto M, Bettio S, et al. Overlap connective tissue disease syndromes. Autoimmun Rev 2013; 12:363–373.
2. Troyanov Y, Targoff IN, Tremblay JL, et al. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: Analysis of 100 French Canadian patients. Medicine 2005; 84 (4): 231–49.
3. Akakpo A, Teclessou J, Mouhari-Touré A, et al. Les sclérodermies en milieu hospitalier à Lomé : étude de 50 cas. Médecine et Santé Tropicale 2017; 24: 446–8.
4. Giannini M, Ellezam B, Leclair V, et al. Scleromyositis: a distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis. Front Immunol 2022, 13: 974078.
5. Diallo M, Fall AK, Diallo I, Diedhiou I, Ba PS, Diagne M et al. Dermatomyositis and polymyositis: 21 cases in Senegal. Med Trop 2010; 70:166–168.
6. Chinniah K, Mody GM. The spectrum of idiopathic inflammatory myopathies in South Africa. Clin Rheumatol. 2021;40:1437–1446.
7. De Lorenzo R, Pinal-fernandez I, Huang W, et al. Muscular and extramuscular clinical characteristics of patients with anti-PM/Scl autoantibodies. Neurology 2018; 90:e2068–e2076.
8. Li B, Yan J, Pu J, Tang J, Xu S, Wang X. Esophageal dysfunction in systemic sclerosis: An update. Rheumatol Ther 2021; 8(4):1535–49.
9. Maurer B, Walker UA. Role of MRI in diagnosis and management of idiopathic inflammatory myopathies. Curr Rheumatol Rep 2015; 17(11):67.
10. Jury EC, D'Cruz D, Morrow WJ. Autoantibodies and overlap syndromes in autoimmune rheumatic disease. J Clin Pathol 2001; 54:340–7.
11. Dia DG, Dia AD, Diagne N, et al. Difficulties in the Management of Systemic Autoimmune Diseases in Saint-Louis Du Senegal through the Analysis of a Series of 70 Observations. OJIM 2021; 11 (4): 258-264.
12. Van den Hoogen F, Khanna D, Fransen J, et al. Classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013; 72(11):1747–55.
13. Ruperto N, Pistorio A, Oliveira, et al. Prednisone versus prednisone plus cyclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomized trial. Lancet 2016; 387(10019): 671–8.